Daisuke Aoki

No ORCID on file · 31 papers in corpus · active 1993-2021

Study types

  • article 27
  • other 2
  • review 2

Condition tags

  • endometriosis 22
  • endometrioma 2
  • adenomyosis 1
article 2021
The American journal of case reports ·doi:10.12659/ajcr.934120

BACKGROUND Endometriosis is defined as the growth of ectopic endometrial tissue beyond the uterine cavity, and endometriosis on the uterine cervix is a rare variant. Although asymptomatic patients with cervical endometriosis or those with m…

article 2017
review 2016
Oncology reports ·doi:10.3892/or.2015.4421

The AT-rich interacting domain‑containing protein 1A gene (ARID1A) encodes ARID1A, a member of the SWI/SNF chromatin remodeling complex. Mutation of ARID1A induces changes in expression of multiple genes (CDKN1A, SMAD3, MLH1 and PIK3IP1) vi…

article 2016
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.13137

AIM: Micro ribonucleic acids (miRNAs) play an important pathological role in endometriosis. Leuprolide acetate, an analog of gonadotropin-releasing hormone, is widely used to treat endometriosis; however, the molecular mechanisms involved i…

other 2015
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1097/IGC.0000000000000377

OBJECTIVE: Synchronous primary endometrial and ovarian cancers have been an important topic in clinical medicine because it is sometimes difficult to distinguish whether there are 2 primary tumors or a single primary tumor and an associated…

article 2015
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.12768

AIM: Leuprolide acetate, an analog of gonadotropin-releasing hormone (GnRH), regresses endometriotic tissue and reduces pain, resulting in clinical improvement upon treatment. The molecular mechanisms involved in the regression of endometri…

article 2015
article 2013
·doi:10.1016/j.jmig.2013.02.008
review 2012
International journal of oncology ·doi:10.3892/ijo.2012.1384

Progestin preparations are made of synthetic progesterone and have often been used for hormone therapy in gynecological patients with endometriosis or endometrial cancer. Hormone therapy using progestin is considered to be one of the effect…

article 2011
European journal of gynaecological oncology

PURPOSE: Ovarian clear cell adenocarcinoma (OCCA) has been reported to display different characteristics from other histological types of epithelial ovarian cancer, and especially differs from serous adenocarcinoma. We investigated plasmino…

article 2011
·doi:10.1016/j.ijgo.2011.05.009
article 2011
International journal of oncology ·doi:10.3892/ijo.2011.1226

Narrow band imaging (NBI) is a new endoscopic technique in which images of mucosal microstructures and capillary structures are enhanced by shifting the light spectrum to a narrow band. Image-enhanced gastrointestinal endoscopy using NBI ha…

article 2010
Nature genetics ·doi:10.1038/ng.612
article 2010
·doi:10.5180/jsgoe.26.401

We present a case of a 19 year-old woman with endometriosis treated by laparoscopy 6 years after a liver transplant. This case had a high risk of visceral injury during trocar insertion. We used cine MRI for evaluation of intra-abdominal ad…

article 2009
·doi:10.5180/jsgoe.25.246

Background; MR images are considered to be highly effective to examine ovarian tumors. However, in some case, it is difficult to differentiate malignant ovarian tumors from benign ones.Methods; Five hundred eighty-nine cases of ovarian tumo…

article 2007
The Journal of reproductive medicine

OBJECTIVE: To investigate the factors related to activation of transforming growth factor-beta 1 (TGF-beta1) at sites of endometriosis. STUDY DESIGN: TGF-beta1 is activated by plasmin, which is formed when plasminogen is activated by urokin…

article 2007
·doi:10.1016/s0167-5273(08)70731-9
other 2006
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2005.11.030

OBJECTIVE: To investigate differences in the biological characteristics of ovarian clear cell adenocarcinoma based on the presence/absence of endometriosis and tumor proliferative activity. METHODS: Stage I ovarian clear cell adenocarcinom…

article 2005
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1111/j.1048-891x.2005.15004.x
article 2005
·doi:10.1136/ijgc-00009577-200501000-00007
article 2001
Nihon rinsho. Japanese journal of clinical medicine
article 2000
article 1999
Gynecologic oncology ·doi:10.1006/gyno.1998.5284
article 1998
European journal of cancer (Oxford, England : 1990) ·doi:10.1016/s0959-8049(97)10079-x
article 1998